US Edition
News from Pharmaphorum
If you want to know if Pharmaphorum is credible or reliable, look no further. We rank Pharmaphorum as High factuality. Find out more about our methodology here.
Media Bias Ratings
Average Bias Rating:
Center
Center
byAd Fontes MediaDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pharmaphorum News
FDA · United StatesThe U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side effects with long-term use, the company said on Thursday.See the Story
Flow Neuroscience wins first FDA approval for at-home brain-stimulation depression treatment
44% Center coverage: 25 sources
PharmaRetatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced.In fact, some of the participants dropped out of the trial because they were losing too much weight, the pharmaceutical company said.Retatrutide is an experimental triple agonist medication, mimicking three different gut hormones in the body GLP-1, G…See the Story
Eli Lilly's Next-Gen Obesity Drug Shows Biggest Weight Loss yet in Clinical Trial
62% Center coverage: 24 sources
